RLA-4842
RLA-4842 is an iron activator containing anti-androgen. RLA-4842 has anti-proliferative activity on metastatic castration-resistant prostate cancer (mCRPC) cell line[1].
Product Specifications
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rla-4842.html
Solubility
10 mM in DMSO
Smiles
CN(C(OC1=CC=C(C=C1)N2C(N(C(C23CCC3)=O)C4=CC(C(F)(F)F)=C(C=C4)C#N)=S)=O)CCN(C(O[C@@H]5CCC[C@@]6(OOC7(C8CC9CC(CC7C9)C8)O6)C5)=O)C
Molecular Formula
C42H46F3N5O8S
Molecular Weight
837.90
References & Citations
[1]Gonciarz RL, et al. Elevated labile iron in castration-resistant prostate cancer is targetable with ferrous iron-activatable antiandrogen therapy. Eur J Med Chem. 2023 Jan 14;249:115110.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![ZNF213 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1A12]](https://cdn.genprice.uk/products/937/6868c409994c49e6dc404666/imageurl/ta810318am.webp)
TA810318AM 100 µL
ZNF213 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1A12]
Sign In for Pricing
View Details 
